Global DNA Vaccine Market 2021

January 2022 | 19 pages | ID: G9A79CC597D1EN
StrategyHelix Inc

Abstracts

A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence onto the cells of an immunized species. DNA vaccines have theoretical advantages over conventional vaccines, including the ability to induce a wider range of types of immune response. The global dna vaccine market is poised to grow by US$ 3,535 million during 2021-2027, progressing at a CAGR of 13.7% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for dna vaccine. The global dna vaccine market is segmented on the basis of type, and region. By type, the global dna vaccine market has been segmented into research tools, clinical vaccines. In 2020, the research tools segment made up the largest share of revenue generated by the dna vaccine market. Geographically, the global dna vaccine market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global dna vaccine market is highly competitive. Key companies profiled in the report include Astellas Pharma Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Gilead Sciences Inc., Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Sanofi Aventis SA.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the dna vaccine market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope
Type: research tools, clinical vaccines
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global dna vaccine market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. DNA VACCINE MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY TYPE

Research tools
Clinical vaccines

PART 4. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 5. KEY COMPANIES

Astellas Pharma Inc.
AstraZeneca plc
Bristol-Myers Squibb Company
Gilead Sciences, Inc.
Johnson & Johnson
Merck & Co.
Novartis AG
Pfizer Inc.
Sanofi Aventis SA
About StrategyHelix
Disclaimer